# Vaginal Baclofen Suppositories in Chronic Pelvic Pain

> **NCT05968937** · PHASE2 · COMPLETED · sponsor: **University of Louisville** · enrollment: 39 (actual)

## Conditions studied

- Chronic Pelvic Pain Syndrome

## Interventions

- **DRUG:** 20 mg baclofen vaginal suppository daily per vagina
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05968937
- **Lead sponsor:** University of Louisville
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-01
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-01-01
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05968937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05968937, "Vaginal Baclofen Suppositories in Chronic Pelvic Pain". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05968937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*